Medication use process and assessment of extemporaneous compounding and alternative routes of administration of oral oncology drugs: Guidance for clinical and oncology pharmacists-Reference-Cited by-同舟云学术

Medication use process and assessment of extemporaneous compounding and alternative routes of administration of oral oncology drugs: Guidance for clinical and oncology pharmacists

Published:2022-09-12 Issue:11 Volume:5 Page:1176-1228
ISSN:2574-9870
Container-title:JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
language:en
Short-container-title:J Am Coll Clin Pharm

Author:

Cohen Jonathan¹²^ORCID,Lee Christopher¹,Markham Ryan¹,Szerwo James¹,Roska Mark¹,Bubalo Joseph¹

Affiliation:

1. Oregon Health & Science University Portland Oregon USA

2. University of Washington Medical Center/Seattle Cancer Care Alliance Seattle Washington USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jac5.1698

Reference200 articles.

1. CenterWatch.FDA Approved Drugs for Oncology.2021. Available from:https://www.centerwatch.com/directories/1067-fda-approved-drugs/topic/103-oncology.

2. Longitudinal trends of utilization, cost, and prevalence in oncology;Erickson S;Am J Pharm Benefits,2014

3. Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions

4. National Cancer Institute.SEER stat fact sheets: All cancer sites[cited 2018 Dec 12]. Available from:http://seer.cancer.gov/statfacts/html/all.html.

5. Extemporaneous Compounding of Oral Liquid Dosage Formulations and Alternative Drug Delivery Methods for Anticancer Drugs

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the intermolecular interactions in the explicitly solvated complexes of lomustine with water and ethanol;Chemical Physics Impact;2023-12

2. Comparative Analysis of Reverse Degree and Entropy Topological Indices for Drug Molecules in Blood Cancer Treatment through QSPR Regression Models;Polycyclic Aromatic Compounds;2023-10-20

3. Pharmaceutical compounding in Russia: analysis of open competitive procurement and segment prospects;Medical Technologies. Assessment and Choice;2023